Results 141 to 150 of about 26,853 (215)

Dosing and Discontinuation of Methylphenidate Medication in Relation to Weight Status in Children and Adolescents. [PDF]

Paediatr Drugs
Izsak J, Kimland EE, Martikainen J, Dahlén E, Halldner L, Kindblom JM.   +5 more
europepmc   +1 more source

Functional Variation in RGS12 Should Not Preclude Methylphenidate Use in Bipolar Disorder with Established Mood Stabilization: Preclinical Evidence. [PDF]

Int J Mol Sci
Agogo-Mawuli PS, Gross JD, Setola V, Gall BJ, Siderovski DP.   +4 more
europepmc   +1 more source

An observational study of once-daily modified-release methylphenidate in ADHD: effectiveness on symptoms and impairment, and safety [PDF]

, 2011
Manfred Döpfner, Anja Görtz‐Dorten, Dieter Breuer, Aribert Rothenberger   +3 more
openalex   +1 more source

Comparative Bioavailability of Methylphenidate Powder for Prolonged-Release Oral Suspension and Methylphenidate Prolonged-Release Chewable Tablets versus Methylphenidate Immediate-Release Tablets: Phase 1, Single-Dose, Randomised, Crossover Studies in Healthy Adults. [PDF]

Clin Drug Investig
Ramos-Quiroga JA, Forcadell Ferré M, Schneider-Pérez A, Bouhajib M.   +3 more
europepmc   +1 more source

A preliminary study on methylphenidate-regulated gene expression in lymphoblastoid cells of ADHD patients

, 2014
Ricarda Schwarz, Andreas Reif, Claus Jürgen Scholz, L. Weißflog, Brigitte Schmidt, Klaus‐Peter Lesch, Christian Jacob, Susanne Reichert, Julia Heupel, Julia Volkert, Juliane Kopf, Max Hilscher, Heike Weber, Sarah Kittel‐Schneider   +13 more
openalex   +2 more sources

Supporting Medication Adherence and Patient-Centered Care for Attention-Deficit Hyperactivity Disorder in Taiwan: A Pharmacist-Oriented Perspective Informed by Targeted Evidence. [PDF]

Patient Prefer Adherence
Chiu YJ, Huang YM.
europepmc   +1 more source

Long-Acting Methylphenidate Toxicity: A Case Report [PDF]

, 2014
Gül Eryılmaz, Işıl Göğçegöz Gül, Özgür Yorbık, Nüket İşiten   +3 more
openalex   +1 more source

Increased Plasma Concentrations of 6-oxo-Methylphenidate in <i>CES1 G134E</i> Carriers Following a Single Oral Dose of Methylphenidate. [PDF]

Med Chem Res
Zhang Q, Melchert PW, Awad A, McCurdy CR, Krone B, Newcorn J, Froehlich TE, Stein MA, Raeuscher J, Zhu HJ, Markowitz JS.   +10 more
europepmc   +1 more source

The association between methylphenidate treatment and the risk for fracture among young ADHD patients: A nationwide population-based study in Taiwan

, 2017
Vincent Chin‐Hung Chen, Yao‐Hsu Yang, Yin‐To Liao, Ting‐Yu Kuo, Hsin‐Yi Liang, Kuo‐You Huang, Yin-Cheng Huang, Yena Lee, Roger S. McIntyre, Tzu-Chin Lin   +9 more
openalex   +2 more sources

Methylphenidate, Sleep, and the "Stimulant Paradox" in Adult ADHD: A Conceptual Framework for Integrating Chronopharmacotherapy and Coaching. [PDF]

J Clin Med
Jaeschke RR, Sułkowska JZ.
europepmc   +1 more source